MIV 818Alternative Names: MIV-818
Latest Information Update: 04 Nov 2016
At a glance
- Originator Medivir AB
- Class Antineoplastics
- Mechanism of Action Polymerase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Hepatocellular carcinoma
Most Recent Events
- 01 Nov 2016 Preclinical trials in Hepatocellular carcinoma in Sweden (PO)
- 30 Jun 2015 Early research in Hepatocellular carcinoma in Sweden (PO)